Related Experiment Video
Updated: Dec 6, 2025

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
[Severe skin and soft tissue infections. An update]
Eleonora R Cunto1, Ángel M Colque2, María Paula Herrera3
1Hospital de Infecciosas Francisco J. Muñiz, Buenos Aires, Argentina.
Abstract:
Severe skin and soft tissue infections present a high morbidity and mortality and require a complex surgical treatment. Its estimated annual incidence is 0.3 to 5 cases per 10 000 people. The most common etiologic agents are Streptococcus pyogenes, Staphylococcus aureus, anaerobes and gram-negative bacilli. A prompt diagnosis and the timely initiation of an empirical antibiotic scheme and repeated surgical debridement can avert a worrisome outcome. New therapeutic options are promising, especially for infections caused by multidrug resistant germs. A multidisciplinary approach is fundamental for the correct management of these conditions.
Insights
Severe skin and soft tissue infections demand complex surgical care due to high risks. Prompt diagnosis, antibiotics, and surgical debridement are crucial for better outcomes, especially with resistant bacteria.
Area of Science:
- Infectious Diseases
- Surgical Infections
- Microbiology
Background:
- Severe skin and soft tissue infections (SSTIs) are associated with significant morbidity and mortality.
- The incidence of SSTIs ranges from 0.3 to 5 cases per 10,000 individuals annually.
- Common causative agents include Streptococcus pyogenes, Staphylococcus aureus, anaerobes, and gram-negative bacilli.
Purpose of the Study:
- To review the management of severe skin and soft tissue infections.
- To highlight the importance of prompt diagnosis and treatment strategies.
- To discuss emerging therapeutic options for multidrug-resistant infections.
Main Methods:
- Literature review on severe skin and soft tissue infections.
- Analysis of common etiologic agents and their resistance patterns.
- Evaluation of current and novel treatment approaches.
Main Results:
- Effective management relies on early diagnosis, empirical antibiotic therapy, and repeated surgical debridement.
- Multidrug-resistant organisms pose a growing challenge in SSTI treatment.
- New therapeutic strategies show promise for combating resistant infections.
Conclusions:
- A multidisciplinary approach is essential for optimal management of severe SSTIs.
- Timely and aggressive intervention can significantly improve patient outcomes.
- Continued research into novel treatments is vital for addressing resistant pathogens.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Burn Injuries
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
Hand hygiene
Hand washing...

